Free Trial

National HealthCare (NHC) Competitors

National HealthCare logo
$129.84 -0.78 (-0.60%)
(As of 11/13/2024 ET)

NHC vs. HIMS, SHC, SGRY, OPCH, GH, PACS, BTSG, LFST, VCYT, and PRVA

Should you be buying National HealthCare stock or one of its competitors? The main competitors of National HealthCare include Hims & Hers Health (HIMS), Sotera Health (SHC), Surgery Partners (SGRY), Option Care Health (OPCH), Guardant Health (GH), PACS Group (PACS), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Veracyte (VCYT), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.

National HealthCare vs.

National HealthCare (NYSE:NHC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

National HealthCare has a net margin of 10.03% compared to Hims & Hers Health's net margin of 8.19%. Hims & Hers Health's return on equity of 10.97% beat National HealthCare's return on equity.

Company Net Margins Return on Equity Return on Assets
National HealthCare10.03% 6.87% 4.68%
Hims & Hers Health 8.19%10.97%8.29%

National HealthCare has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.

In the previous week, Hims & Hers Health had 34 more articles in the media than National HealthCare. MarketBeat recorded 41 mentions for Hims & Hers Health and 7 mentions for National HealthCare. National HealthCare's average media sentiment score of 1.11 beat Hims & Hers Health's score of 0.74 indicating that National HealthCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National HealthCare
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
12 Very Positive mention(s)
4 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National HealthCare has higher revenue and earnings than Hims & Hers Health. National HealthCare is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National HealthCare$1.14B1.78$66.80M$7.9816.51
Hims & Hers Health$872M6.93-$23.55M$0.4463.98

Hims & Hers Health received 35 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 37.11% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
National HealthCareOutperform Votes
1
100.00%
Underperform Votes
No Votes
Hims & Hers HealthOutperform Votes
36
37.11%
Underperform Votes
61
62.89%

56.4% of National HealthCare shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 13.8% of National HealthCare shares are held by insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Hims & Hers Health has a consensus price target of $21.21, suggesting a potential downside of 24.64%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than National HealthCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National HealthCare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Hims & Hers Health
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Hims & Hers Health beats National HealthCare on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NHC vs. The Competition

MetricNational HealthCareSkilled nursing care facilities IndustryMedical SectorNYSE Exchange
Market Cap$2.03B$3.46B$5.24B$20.06B
Dividend Yield1.87%1.02%4.99%3.50%
P/E Ratio16.5119.1586.3836.88
Price / Sales1.781.311,304.9018.70
Price / Cash21.2516.3038.9621.64
Price / Book2.063.496.484.70
Net Income$66.80M$98.56M$118.16M$982.08M
7 Day Performance1.08%4.96%-0.07%0.41%
1 Month Performance9.43%-8.97%5.61%2.73%
1 Year PerformanceN/A23.18%42.32%31.55%

National HealthCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NHC
National HealthCare
N/A$129.84
-0.6%
N/AN/A$2.00B$1.14B16.2713,123Dividend Announcement
Positive News
HIMS
Hims & Hers Health
3.6922 of 5 stars
$23.41
-0.9%
N/A+294.3%$5.03B$872M53.211,046Short Interest ↑
Gap Up
SHC
Sotera Health
3.1757 of 5 stars
$16.09
+1.6%
N/A+17.2%$4.56B$1.05B64.363,000Gap Up
SGRY
Surgery Partners
2.7568 of 5 stars
$30.36
-0.2%
N/A-4.5%$3.86B$2.89B-112.4413,500Analyst Forecast
News Coverage
OPCH
Option Care Health
4.981 of 5 stars
$22.48
-2.0%
N/A-21.9%$3.83B$4.30B18.897,802Insider Buying
Short Interest ↓
GH
Guardant Health
4.6903 of 5 stars
$28.61
+0.1%
N/A+39.7%$3.53B$692.26M-6.751,779Earnings Report
Short Interest ↓
PACS
PACS Group
3.4761 of 5 stars
$21.33
+7.6%
N/AN/A$3.25B$3.11B0.0032,433Gap Up
High Trading Volume
BTSG
BrightSpring Health Services
2.9013 of 5 stars
$19.57
+3.4%
N/AN/A$3.20B$8.83B-75.2735,000Short Interest ↓
LFST
LifeStance Health Group
1.8256 of 5 stars
$7.36
-4.2%
N/A+27.8%$2.82B$1.06B-17.959,325Earnings Report
Analyst Forecast
Analyst Revision
High Trading Volume
VCYT
Veracyte
4.2038 of 5 stars
$36.48
-2.3%
N/A+72.2%$2.80B$361.05M-243.20790Earnings Report
PRVA
Privia Health Group
3.3677 of 5 stars
$21.30
-5.5%
N/A+2.6%$2.55B$1.66B177.511,102

Related Companies and Tools


This page (NYSE:NHC) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners